Safety and Efficacy of Early Administration of Dexamethasone in High-risk Sepsis
NCT05136560 · Status: RECRUITING · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 102
Last updated 2025-05-31
Summary
The purpose of this study is to investigate the safety and efficacy of early administration of two different doses of dexamethasone in high risk septic patients.
Conditions
Interventions
- DRUG
-
Intervention drugs would be administered for 1 or 2 days.
Sponsors & Collaborators
-
CHA University
lead OTHER
Principal Investigators
-
Kyuseok Kim, M.D, PhD · Bundang CHA Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- QUADRUPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 19 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-01-15
- Primary Completion
- 2025-12-30
- Completion
- 2026-02-28
Countries
- South Korea
Study Locations
More Related Trials
-
Effects of Dexmedetomidine on Respiratory Function and Inflammatory Responses in Patient With Sepsis Undergoing Cleaning Focus of Infection
NCT02842437 ·Status: UNKNOWN ·Phase: NA
-
Dendritic Cells-Derived Exosomes in Human Sepsis
NCT02957279 ·Status: UNKNOWN
-
Early Tranexamic Acid and Modulating the Inflammatory Response in Sepsis
NCT04910464 ·Status: RECRUITING ·Phase: PHASE3
-
Dex on Microcirculation in SS-A Double-blinded Study
NCT02612181 ·Status: UNKNOWN ·Phase: PHASE4
-
Study of Early Enteral Dextrose in Sepsis
NCT03454087 ·Status: COMPLETED ·Phase: NA
-
Adjunctive Granisetron Therapy in Patients With Sepsis or Septic Shock
NCT03924518 ·Status: COMPLETED ·Phase: PHASE2
-
Methylene Blue in Severe Sepsis and Septic Shock
NCT01797978 ·Status: UNKNOWN ·Phase: PHASE3
-
Dexmedetomidine on Microcirculation in Septic Shock
NCT02270281 ·Status: COMPLETED ·Phase: PHASE4
-
A Multicenter, Randomized, Double-blind, Placebo-controlled Phase II Dose Exploration Clinical Trial Evaluating the Efficacy, Safety, and Pharmacokinetic Characteristics of STC314 Injection Administered Intravenously in Sepsis Patients
NCT06548854 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Rapid Recognition of Corticosteroid Resistant or Sensitive Sepsis
NCT04280497 ·Status: RECRUITING ·Phase: NA
-
A Safety and Efficacy Study of Intravenous E5564 in Patients With Severe Sepsis
NCT00046072 ·Status: COMPLETED ·Phase: PHASE2
-
Statins for the Early Treatment of Sepsis
NCT00528580 ·Status: TERMINATED ·Phase: PHASE2
-
Prolonged Intravenous Infusion of β-lactam Antibiotics in Early Septic Patients
NCT05024565 ·Status: UNKNOWN ·Phase: NA
-
Pharmacokinetics and Pharmacodynamics of High Dose Ceftriaxone in Patients With Sepsis
NCT07245966 ·Status: COMPLETED
-
Early Vasopressors in Sepsis
NCT05179499 ·Status: RECRUITING ·Phase: PHASE3
-
Study of Multiple-dose Kukoamine B Mesilate in Sepsis Patients
NCT03237728 ·Status: COMPLETED ·Phase: PHASE1
-
Effect of Dexmedetomidine on Perfusion Index and Microcirculation in Severe Sepsis and Septic Shock Patients
NCT03151668 ·Status: UNKNOWN ·Phase: PHASE3
-
Early Goal Directed Sedation on Microcirculation in Septic Shock
NCT02612363 ·Status: UNKNOWN ·Phase: PHASE4
-
Phase 3 Safety and Efficacy Study of ART-123 in Subjects With Severe Sepsis and Coagulopathy
NCT01598831 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of Anisodamine Hydrobromide Combined With Low-molecular-weight Heparin in the Treatment of Patients With Sepsis
NCT05634057 ·Status: RECRUITING ·Phase: NA
-
Endotoxin Activity Assay and Microcirculation in Severe Sepsis
NCT02452138 ·Status: UNKNOWN
-
Clinical Trial to Evaluate MDW for Early Detection of Sepsis
NCT06267742 ·Status: ACTIVE_NOT_RECRUITING
-
Identification and Clinical Efficacy Analysis of Biomarkers in Sepsis Patients
NCT05911711 ·Status: UNKNOWN
-
Early Intravenous Hydrocortisone in Sepsis
NCT06217939 ·Status: RECRUITING ·Phase: NA
-
Hemodynamic Effects of Dexmedetomidine in Septic Shock
NCT02638545 ·Status: COMPLETED ·Phase: PHASE3